• ClipSaver
ClipSaver
Русские видео
  • Смешные видео
  • Приколы
  • Обзоры
  • Новости
  • Тесты
  • Спорт
  • Любовь
  • Музыка
  • Разное
Сейчас в тренде
  • Фейгин лайф
  • Три кота
  • Самвел адамян
  • А4 ютуб
  • скачать бит
  • гитара с нуля
Иностранные видео
  • Funny Babies
  • Funny Sports
  • Funny Animals
  • Funny Pranks
  • Funny Magic
  • Funny Vines
  • Funny Virals
  • Funny K-Pop

334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more скачать в хорошем качестве

334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more 3 months ago

Peter Attia MD

Dr. Peter Attia

Early Medical

The Drive Podcast

The Drive

Longevity

Zone 2

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more
  • Поделиться ВК
  • Поделиться в ОК
  •  
  •  


Скачать видео с ютуб по ссылке или смотреть без блокировок на сайте: 334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more в качестве 4k

У нас вы можете посмотреть бесплатно 334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:

  • Информация по загрузке:

Скачать mp3 с ютуба отдельным файлом. Бесплатный рингтон 334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more в формате MP3:


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса ClipSaver.ru



334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more

Tom Dayspring is a world-renowned expert in clinical lipidology & a previous guest on The Drive. In this episode, Tom explores the foundations of atherosclerosis & why atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide for both men & women. He examines how the disease develops from a pathological perspective & discusses key risk factors, including often-overlooked contributors such as insulin resistance & chronic kidney disease. He breaks down the complexities of cholesterol & lipoproteins with an in-depth discussion on the critical role of apolipoprotein B (apoB) in the development of atherosclerosis. He covers the importance of testing various biomarkers, the impact of nutrition on lipid levels, & the vital role of cholesterol in brain health, including how cholesterol is synthesized & managed in the brain, how it differs from cholesterol regulation in the rest of the body, & how pharmacological interventions can influence brain cholesterol metabolism. View show notes here: https://bit.ly/3WFZURi Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ We discuss: 0:00:00-Intro 0:01:07-Defining atherosclerotic cardiovascular disease (ASCVD) 0:09:52-The pathogenesis of ASCVD: the silent development over decades 0:16:52-Risk factors versus risk markers, & how insulin resistance & chronic kidney disease contribute to atherosclerosis 0:24:19-How hyperinsulinemia elevates cardiovascular risk 0:30:30-How apoB-containing lipoproteins contribute to atherosclerosis, & why measuring apoB is the superior indicator of cardiovascular risk 0:48:08-Challenges of detecting early-stage atherosclerosis before calcification appears 0:57:50-Lp(a): structure, genetic basis, & significant risks associated with elevated Lp(a) 1:02:30-How aging & lifestyle factors contribute to rising apoB & LDL cholesterol levels, & the lifestyle changes that can lower it 1:11:32-How elevated triglycerides, driven by insulin resistance, increase apoB particle concentration & promote atherosclerosis 1:25:59-How LDL particle size, remnant lipoproteins, Lp(a), & non-HDL cholesterol contribute to cardiovascular risk beyond apoB levels 1:33:25-Limitations of using HDL cholesterol as a marker for heart health 1:41:35-Critical role of cholesterol in brain function & how the brain manages its cholesterol supply 1:51:40-Impact of ApoE genotype on brain health & Alzheimer's disease risk 1:56:18-How the brain manages cholesterol through specialized pathways, & biomarkers to track cholesterol health of the brain 2:03:43-How statins might affect brain cholesterol synthesis & cognitive function, & alternative lipid-lowering strategies for high-risk individuals 2:16:20-Exciting advancements in therapeutics, diagnostics, & biomarkers coming in the next few years 2:19:33-Recent consensus statements on apoB & Lp(a) from the National Lipid Association (NLA) -------- About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

Comments
  • Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast 3 years ago
    Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast
    Опубликовано: 3 years ago
    292644
  • 337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more 2 months ago
    337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more
    Опубликовано: 2 months ago
    241604
  • Dr. Thomas Dayspring - World-Renowned Expert in Lipidology 2 weeks ago
    Dr. Thomas Dayspring - World-Renowned Expert in Lipidology
    Опубликовано: 2 weeks ago
    9630
  • 210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D. 2 years ago
    210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
    Опубликовано: 2 years ago
    105865
  • Simple Habits That Could Add Decades To Your Life - Dr Peter Attia 2 years ago
    Simple Habits That Could Add Decades To Your Life - Dr Peter Attia
    Опубликовано: 2 years ago
    467376
  • What Big Pharma Doesn’t Want You to Know About Statins | Dr. Aseem Malhotra 3 months ago
    What Big Pharma Doesn’t Want You to Know About Statins | Dr. Aseem Malhotra
    Опубликовано: 3 months ago
    149274
  • Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253 2 years ago
    Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253
    Опубликовано: 2 years ago
    45527
  • How Fructose Drives Metabolic Disease | Rick Johnson, M.D. 3 years ago
    How Fructose Drives Metabolic Disease | Rick Johnson, M.D.
    Опубликовано: 3 years ago
    198417
  • Programming ▫️ Coding ▫️ Hacking ▫️ Designing Music 🦠 9 months ago
    Programming ▫️ Coding ▫️ Hacking ▫️ Designing Music 🦠
    Опубликовано: 9 months ago
    1220172
  • 333 ‒ Longevity roundtable—the science of aging, geroprotective molecules, & lifestyle interventions 3 months ago
    333 ‒ Longevity roundtable—the science of aging, geroprotective molecules, & lifestyle interventions
    Опубликовано: 3 months ago
    82506

Контактный email для правообладателей: [email protected] © 2017 - 2025

Отказ от ответственности - Disclaimer Правообладателям - DMCA Условия использования сайта - TOS